The Sartorius AG logo can be seen on the company's building. Swen Pförtner/dpa German pharma and lab supplier Sartorius reported that fiscal 2023 profit to equity holders of Sartorius AG declined to ...

Sartorius AG is rebounding with strong bioprocess segment growth and improving profit margins, despite a challenging ...

Sartorius announced the 2.4 billion euro acquisition of Polyplus. Polyplus is producing transfection reagents and generates 100 million euros in revenues. The acquisition appears to be very expensive ...

GOTTINGEN, Germany - March 27, 2025 (NEWMEDIAWIRE) - The life science group Sartorius held its virtual Annual General Meeting today. The shareholders approved all proposals of the Supervisory Board ...

We are transferring coverage of Sartorius AG and its bioprocessing subsidiary Sartorius Stedim Biotech, or SSB. We maintain our wide moat ratings for both companies due to the high regulatory hurdles ...

GOTTINGEN, Germany--(BUSINESS WIRE)--At today’s Annual Shareholders’ Meeting of Sartorius AG in Göttingen, Germany, shareholders approved the board's proposals by a large majority. The Annual ...

GÖTTINGEN, Germany, Oct. 13, 2021 /PRNewswire/ -- Karin Sartorius-Herbst and LifeScience Holding SCSp ("LSH") have entered into option agreements to acquire a total portion of approximately 56.7 ...

SARTORIUS AG (SARTF) came out with quarterly earnings of $0.81 per share, beating the Zacks Consensus Estimate of $0.65 per share. This compares to earnings of $0.66 per share a year ago. These ...

Management at wide-moat companies Sartorius AG SRT3 and its bioprocessing subsidiary Sartorius Stedim DIM significantly reduced 2023 guidance, as demand for their life science tools have softened in ...

Feb 25 (Reuters) - Laboratory supplies vendor Sartorius AG (SATG.DE), opens new tab has approached Maravai LifeSciences Holdings Inc (MRVI.O), opens new tab, a U.S. provider of capping reagents for ...